Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Radial Access Is Always Preferred, Even for Treatment of the Left Main Coronary Artery

The potential need for a 7-Fr guidewire, the use of several coronary guidewires and/or a kissing balloon, and the requirement of indispensable monitoring by intravascular ultrasound (IVUS) have been used by some interventional cardiologists as excuses to resist radial access. In that sense, left main coronary artery angioplasty was the last stand of femoral access.

acceso_radialThis no longer matches what goes on in contemporary practice: radial access has become the dominant access for unprotected left main coronary artery angioplasty and it is associated with shorter hospital stay, less vascular complications, and less major bleeding related to femoral access.

 

Using data from the British Cardiovascular Intervention Society database, researchers assessed temporal trends, predictors, and outcomes of radial access versus femoral access to treat unprotected left main coronary artery. A total of 19,482 left main coronary artery angioplasties conducted between 2007 and 2014 were analyzed, using logistic regression to identify predictors of access site choice and its outcomes.


Read also: Balloon-Expandable vs. Self-Expanding: To Each Valve Its Own Annulus.


The frequency of femoral access use fell from 77.7% in 2007 to 31.7% in 2014 (p < 0.001 for trend). In the most recent years analyzed, there was a strong association between femoral access use and chronic kidney disease, restenosis treatment, total occlusion associated, and female sex.

 

Use of intravascular ultrasound and chronic anticoagulation were more strongly associated with radial access use. The anatomical complexity of patients treated through this access increased significantly as years went by.

 

The length of stay was shorter (2.6 ± 9.2 vs. 3.6 ± 9.0; p < 0.001) and same-day discharge was significantly more frequent with radial access (43.0% vs. 26.6%; p < 0.001).


Read also: Everolimus-Eluting Stents Finally Have a Rival and Not Just a “Non-Inferior” Stent.


After multiple adjustments through propensity score matching, radial access was associated with significant reductions in in-hospital events, including access site complications, major bleeding, and major adverse cardiovascular events, but it was not associated with lower mortality.

 

Original title: Access Site and Outcomes for Unprotected Left Main Stem Percutaneous Coronary Intervention. An Analysis of the British Cardiovascular Intervention Society Database.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...